Quarterly Results announcement form
     
Name of listed company                  :SIIC Medical Science and Technology (Group) Limited
     
Stock code                              :8018
     
Year end date                           :31/12/2002
     
Auditors' report                        :   Modified
                                            Qualified
                                            Unqualified
                                          X N/A
     
Important Note :
     
This result announcement form only contains extracted information from
and should be read in conjunction with the detailed results announcement
of the issuer, which can be viewed on the GEM website at
http://www.hkgem.com
     
Currency: HK$'000
                                          (Unaudited)       (Unaudited)
Quarterly Results Announcement                Current              Last 
                                                          Corresponding
                                               Period            Period
                                      from 01/01/2002   from 01/01/2001
                                        to 30/06/2002     to 30/06/2001
                                              HK$'000           HK$'000
     
Turnover                             :        419,884           339,402
Profit/(Loss) from Operations        :         88,217            71,865
Finance cost                         :              0                 0
Share of Profit/(Loss) of Associates :         16,208            17,933
Share of Profit/(Loss) of
     Jointly Controlled Entites      :             -5               -27
Profit/(Loss) after Taxation & MI    :         45,518           198,914
% Change Over the Last Period        :       -77.12 %
EPS / (LPS) - Basic                  :   HK7.34 cents     HK32.08 cents
            - Diluted                :   HK7.29 cents               N/A
Extraordinary (ETD) Gain/(Loss)      :              0                 0
Profit (Loss) after ETD Items        :         45,518           198,914
2nd Q Dividend per Share             :            Nil               Nil
(specify if with other options)      :            N/A               N/A
B/C Dates for 2nd Q Dividend         :            N/A to       N/A bdi.
Payable Date                         :               N/A
B/C Dates for AGM/SGM                :            N/A to       N/A bdi.
Other Distribution for Current Period:               Nil
B/C Dates for Other Distribution     :            N/A to       N/A bdi.
                                             (bdi: both days inclusive)
     
                                                       For and on behalf of
                                         SIIC Medical Science and Technology (Group) Limited
                           Signature :
                           Name      :                 Wong Mei Ling, Marina
                           Title     :                   Company Secretary
     
Responsibility statement
     
The directors of the Company (the "Directors") as at the date hereof
hereby collectively and individually accept full responsibility for the
accuracy of the information contained in this results announcement form
(the "Information") and confirm, having made all reasonable inquiries, that
to the best of their knowledge and belief the Information are accurate and
complete in all material respects and not misleading and that there are no
other matters the omission of which would make the Information herein
inaccurate or misleading. The Directors acknowledge that the Stock
Exchange has no responsibility whatsoever with regard to the Information
and undertake to indemnify the Exchange against all liability incurred and
all losses suffered by the Exchange in connection with or relating to
the Information.
     
Remarks:
     
1. General Information
     
The Company is a listed public limited company incorporated in 
Cayman Islands. The shares of the Company are listed on the 
Growth Enterprise Market of The Stock Exchange of Hong Kong 
Limited (the "GEM").  Its utlimate holding company is Shanghai 
Industrial Investment (Holdings) Company Limited, incorporated 
in Hong Kong.
     
The Company is an investment holding company.
     
2. Turnover
     
Turnover represented the net amounts received and receivable for 
goods sold by the Group to outside customers during the period.
     
3. Profit from operations
     
During the period, the profit from operations was principally come
from Chia Tai Qingchunbao Pharmaceutical Co., Ltd. 
(正大青春寶藥業有限公司).
     
4.  Gain on deemed disposal of interests in a jointly controlled 
    entity
     
An exceptional gain of HK$155 million has been made in the last 
corresponding period which represents gain on deemed disposal of
interests in a jointly controlled entity, Shanghai Jahwa.  The 
Group's interests in Shanghai Jahwa was diluted from 40% to 28.15% 
after the listing of Shanghai Jahwa's shares on the Shanghai Stock 
Exchange A Shares Market.
     
5.  Earnings per share
     
The calculation of the basic and diluted earnings per share is 
based on the following data:
     
                                      Six months ended 30th June
                                         2002              2001
Earnings:
     
Net profit for the period and 
earnings for the purpose of basic
and diluted earnings per share        HK$45,518,000   HK$198,914,000
                                      =============   =============
Number of shares:
     
Weighted average number of 
ordinary shares for the 
purpose of basic earnings 
per share                               620,000,000     620,000,000
     
Effect of dilutive potential
ordinary shares - share options           4,071,419               -
                                      _____________   _____________
Weighted average number of 
ordinary shares for the purpose
of diluted earnings per share           624,071,419     620,000,000
                                      =============   =============